Copy of Sublicenses and Sublicensee Royalty Reports. Eidos will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports, which may in each case be reasonably redacted for information not relevant to this Agreement. Beginning with the first Sublicense, the Chief Financial Officer or equivalent of Eidos will certify annually regarding the name and number of sublicensees.
Appears in 4 contracts
Samples: Exclusive (Equity) Agreement, Exclusive (Equity) Agreement (BridgeBio Pharma, Inc.), Exclusive (Equity) Agreement (BridgeBio Pharma LLC)
Copy of Sublicenses and Sublicensee Royalty Reports. Eidos Eiccose will submit to Stanford a copy of each Sublicense, any subsequent amendments and all copies of sublicensees’ royalty reports, which may in each case be reasonably redacted for of any information that is not relevant necessary to confirm compliance with this Agreement. Beginning with the first Sublicense, the Chief Financial Officer or equivalent of Eidos Eiccose will certify annually regarding the name and number of sublicensees.
Appears in 2 contracts
Samples: Exclusive Agreement (Celladon Corp), Exclusive Agreement (Celladon Corp)